HCM
DVAX

Highbridge Capital Management’s Dynavax Technologies DVAX Stock Holding History

Highbridge Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-86,257
Closed -$513K – 1330
2017
Q1 		$513K Buy
+86,257
New +$415K 0.01% 892
2016
Q4 		– Sell
-32,726
Closed -$343K – 1324
2016
Q3 		$343K Buy
+32,726
New +$470K 0.01% 959
2015
Q4 		– Sell
-34,738
Closed -$852K – 1554
2015
Q3 		$852K Buy
+34,738
New +$984K 0.01% 843

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Highbridge Capital Management's DVAX Position: Q2 2017 in Review

Highbridge Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2017, closing a stake of 86,257 shares — an estimated $513K sold.

Highbridge Capital Management first reported a position in DVAX in Q3 2015 and held it in 3 quarters. The position peaked at $852K in Q3 2015. 111 funds tracked by Wall St. Rank hold DVAX as of Q2 2017.

  • Highbridge Capital Management reported no remaining Dynavax Technologies position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 86,257 Dynavax Technologies shares in Q2 2017, an estimated $513K.
  • Highbridge Capital Management first reported a position in Dynavax Technologies in Q3 2015 and held it in 3 quarters.
  • Highbridge Capital Management's Dynavax Technologies position peaked at $852K in Q3 2015.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.